SCHEMBL31065875

SCHEMBL31065875

O=C(O)c1cc(Oc2c(F)cc3[nH]ccc3c2F)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PRKAB2 O43741 6/20 0.41
▸ PRKAG1 P54619 6/20 0.41
▸ PRKAA2 P54646 6/20 0.41
▸ PRKAA1 Q13131 6/20 0.41
▸ PRKAG3 Q9UGI9 6/20 0.41
▸ PRKAG2 Q9UGJ0 6/20 0.41
▸ PRKAB1 Q9Y478 6/20 0.41
▸ RHEB Q15382 2/20 0.35
▸ AURKA O14965 1/20 0.34
▸ TPX2 Q9ULW0 1/20 0.34
▸ TRPA1 O75762 1/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ ADRB1 P08588 1/20 0.33
▸ ADRB3 P13945 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ XDH P47989 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30840391 0.88 PRKAB2 (0.40) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL31108631 0.87 NR4A2 (0.39) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL27283024 0.85 PRKAB2 (0.38) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL30840100 0.85 PRKAB2 (0.38) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL30967786 0.85 PRKAB2 (0.40) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL31111053 0.84 RHEB (0.34) RHEBTRPA1DRD1
SCHEMBL27382327 0.84 TRPA1 (0.36) RHEBTRPA1DRD1
SCHEMBL30217128 0.82 TRPA1 (0.34) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL31110672 0.81 PRKAB2 (0.40) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL31110712 0.81 DRD1 (0.33) RHEBTRPA1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673139-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME Sionna Therapeutics Inc. (US) 2026-01-07 — — EP disclosed
EP-4673141-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME Sionna Therapeutics Inc. (US) 2026-01-07 — — EP disclosed
EP-4673137-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME Sionna Therapeutics Inc. (US) 2026-01-07 — — EP disclosed
WO-2024182742-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME SIONNA THERAPEUTICS INC. (US) 2024-09-06 — — WO disclosed
WO-2024182736-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME SIONNA THERAPEUTICS INC. (US) 2024-09-06 — — WO disclosed
WO-2024182751-A1 NBD1 MODULATORS AND METHODS OF USING THE SAME SIONNA THERAPEUTICS INC. (US) 2024-09-06 — — WO disclosed
Send feedback